Publication: GOG-3119/ENGOT-en29/TroFuse-033: A phase III, randomized study of sacituzumab tirumotecan (sac-TMT) + pembrolizumab (pembro) vs pembro alone as first-line (1L) maintenance therapy for mismatch repair-proficient (pMMR) endometrial cancer (EC)
Program
KU-Authors
KU Authors
Co-Authors
Eminowicz, G.
Alexandre, J.
Sanchez, L. M. M.
Braicu, I.
Madry, R.
Farolfi, A.
Vulsteke, C.
Hasegawa, K.
Wang, J.
Kim, J.
Editor & Affiliation
Compiler & Affiliation
Translator
Other Contributor
Date
Language
eng
Type
Embargo Status
N/A
Journal Title
Journal ISSN
Volume Title
Alternative Title
Abstract
Source
Publisher
Elsevier
Subject
Health sciences, Medicine, Oncology
Citation
Has Part
Source
Annals of Oncology
Book Series Title
Edition
DOI
10.1016/j.annonc.2025.08.1856
item.page.datauri
Link
Rights
N/A
Copyrights Note
Creative Commons license
Except where otherwised noted, this item's license is described as N/A